Atrial Fibrillation Progression Trial

NCT ID: NCT01570361


Title
Atrial Fibrillation Progression Trial
Purpose
The objective of this study is to determine whether early radiofrequency (RF) ablation treatment, using the CARTO® 3 or CARTO® XP System, and THERMOCOOL® Catheter Family (including THERMOCOOL® SF or THERMOCOOL® SMARTTOUCHâ„¢) in subjects with paroxysmal atrial fibrillation (PAF), delays progression of atrial fibrillation (AF) compared with drug therapy (either rate or rhythm control) using current AF management guidelines.
Details
Eligible PAF subjects with recurrent AF for 2 years who have failed no more than 2 prescribed drugs (with either anti-arrhythmic or rate control drug) are randomized into one of two study arms (catheter ablation or drug therapy).
Conditions
Atrial Fibrillation
Keywords
Atrial Fibrillation, Arrhythmias, Cardiac, Heart Diseases, Cardiovascular Diseases, Pathologic Processes
Source
Biosense Webster, Inc.
Sponsors
Biosense Webster, Inc.
Status
Recruiting
Acronym
ATTEST
Last Updated
17 Jan 2017
URL
Official Link
Locations
Australia, Austria, Belgium, Germany, Hungary, Ireland, Italy, Korea, Republic of, Latvia, Norway, Poland, Russian Federation, Spain, Sweden, United Kingdom, Czech Republic